Amylyx Pharmaceuticals, Inc. (AMLX) Technical Analysis & Indicators
Amylyx Pharmaceuticals, Inc. (AMLX) — Price $28.04 (closing price, November 2, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Amylyx Pharmaceuticals, Inc. (AMLX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor.